IP Verse

Novartis Pharmaceuticals Corporation v. Shilpa Pharma, Inc. - IPR2022-00886

Explore the PTAB proceeding IPR2022-00886 filed by Novartis Pharmaceuticals Corporation against Shilpa Pharma, Inc. on Apr 20, 2022. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2022-00886
Filing Date
Apr 20, 2022
Petitioner
Novartis Pharmaceuticals Corporation
Respondent
Shilpa Pharma, Inc.
Status
Final Written Decision
Respondent Application Number
13635207
Respondent Tech Center
1600
Respondent Patent Number
9266816
Institution Decision Date
Oct 26, 2022
Termination Date
Sep 29, 2023

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2022-00886.

TypeName
Petitioner CounselLove, Janeet al
Respondent CounselBoland, Market al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.